Lantern Pharma
LTRN
#9652
Rank
S$57.53 M
Marketcap
$5.33
Share price
-0.77%
Change (1 day)
-4.57%
Change (1 year)

Lantern Pharma (LTRN) - P/B ratio

P/B ratio as of January 2025 : 1.52

According to Lantern Pharma's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Lantern Pharma - P/B ratio (from 2020 to 2024)

202120222023202420251234567companiesmarketcap.com

P/B ratio by year

Year P/B ratio Change
2024-12-311.3923.59%
2023-12-311.12-4.12%
2022-12-311.17-6.19%
2021-12-311.25-79.47%
2020-12-316.08
2019-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.09 36.92%๐Ÿ‡บ๐Ÿ‡ธ USA